In a reflection on the Annual Meeting, Anupama Datha, a health research assistant at ONE, pinpoints why the meeting is valuable for global health professionals who might not come from a medical or scientific background. Here’s an excerpt (the bold is our emphasis):
I’d always known about the issue, but hearing speakers as widely ranged as Margareth Ndomondo-Sigonda of the African Union’s regulatory arm to Connie Jung of the FDA’s Office of Drug Security discuss regulatory policy and scientific developments with first-hand experience helped me appreciate just how difficult it is to control and fight fake medicines and showed how prevalent the problem is.
The main reason I found these issues – all things I already knew about – so interesting was because I had a chance to hear about them from a new perspective. And that only reinforces the value of multidisciplinary conferences like this one, where people from all parts of the issue get together. Next year’s conference is in New Orleans – hope to see you there!
Crowd listens to presentation at an Annual Meeting symposium.